… and/or marked elevations in markers of COVID-19-associated coagulopathy. However, the
… and high clinical suspicion of venous thromboembolism, therapeutic anticoagulation should …

… coronavirus disease 2019 (COVID-19) has been associated with elevated rates of
thromboembolic … The majority of thrombotic events represent venous thromboembolism (VTE) and …

… Systematic review and meta-analysis of the prevalence of venous thromboembolic events
in novel coronavirus disease-2019 patients. J Vasc Surg Venous Lymphat Disord 2021; 9: 289…

… of low molecular weight heparin in all COVID-19 patients. However, the … of venous
thromboembolism (VTE) in severe COVID-19 patients. One study report a 27% rate of VTE in COVID-…

… Scientific and Standardization Committee communication: clinical guidance on the diagnosis,
prevention, and treatment of venous thromboembolism in hospitalized patients with COVID…

Venous thromboembolism (VTE) is the third most common cause of vascular mortality
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In this …

… and complications of this disease has received a great deal of … coronavirus 2 is the
occurrence of venous thromboembolic … acute respiratory syndrome coronavirus 2 infection along …

… coronavirus 2 (SARS-CoV-2), and coronavirus disease 2019 (COVID-19), has caused
more than 3.9 million cases worldwide. Currently, there is great interest to assess venous …

… Coronavirus disease 2019 is associated with a strikingly high prevalence of coagulopathy
and venous thromboembolism that … may trigger screening for venous thromboembolism. In all …

… among patients infected with the novel coronavirus disease-19. … overview of venous
thromboembolism prevalence based on 19 studies involving 2,520 hospitalized COVID-19 patients. …